Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has ...

GameStop announced an offering of up to 20 million shares. In Q2, GameStop reported revenue of $798.3 million, compared to $1 ...

Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

“This upcoming season, we look forward to Beyfortus offering its demonstrated real-world protection to as many infants as ...

Fulcrum Therapeutics (FULC) stock falls 70% as lead asset, losmapimod licensed from GSK (GSK) fails in a Phase 3 trial against a rare muscle disorder. Read more here.

The Bank of England could cut interest rates to 2.75pc next year, analysts have suggested, amid growing confidence that the ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

During that time, Zhifei had the opportunity to also partner with another multinational company, GSK for Shingrix ... whether it's Latin America, EMEA, AP. Got it. So I guess private markets will be ...